Suchergebnisse - "Power, Christopher"

PubPharm (286)

41

Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2

enthalten in: Antimicrobial agents and chemotherapy | 2021

von Limonta, D. | Dyna-Dagman, L. | Branton, W. | +5

42

Long-term consequences of interpersonal violence experiences on treatment engagement and health status in people living with HIV

enthalten in: AIDS (London, England) | 2021

von Budd, A. | Krentz, H. | Rubin, L. | +3

43

Modeling the Effects of Latency Reversing Drugs During HIV-1 and SIV Brain Infection with Implications for the "Shock and Kill" Strategy

enthalten in: Bulletin of mathematical biology | 2021

von Roda, W. | Liu, S. | Power, C. | +1

44

Modeling the Effects of Latency Reversing Drugs During HIV-1 and SIV Brain Infection with Implications for the “Shock and Kill” Strategy

enthalten in: Bulletin of mathematical biology | 2021

von Roda, W. | Liu, S. | Power, C. | +1

45

Modeling the Effects of Latency Reversing Drugs During HIV-1 and SIV Brain Infection with Implications for the “Shock and Kill” Strategy

enthalten in: Bulletin of mathematical biology | 2021

von Roda, W. | Liu, S. | Power, C. | +1

46

Modeling the Effects of Latency Reversing Drugs During HIV-1 and SIV Brain Infection with Implications for the “Shock and Kill” Strategy

enthalten in: Bulletin of mathematical biology | 2021

von Roda, W. | Liu, S. | Power, C. | +1

47

Intracellular nickel accumulation induces apoptosis and cell cycle arrest in human astrocytic cells

enthalten in: Metallomics : integrated biometal science | 2021

von Yubolphan, R. | Phuagkhaopong, S. | Sangpairoj, K. | +3

48

Neurocognitive Impairment and Associated Genetic Aspects in HIV Infection

enthalten in: Current topics in behavioral neurosciences | 2021

von Gomez, D. | Power, C. | Fujiwara, E.

49

Intranasal anti-caspase-1 therapy preserves myelin and glucose metabolism in a model of progressive multiple sclerosis

enthalten in: Glia | 2021

von Saito, L. | Fernandes, J. | Smith, M. | +8

50

Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period

enthalten in: AIDS (London, England) | 2021

von Rourke, S. | Bekele, T. | Rachlis, A. | +7

CommentIn: AIDS. 2021 Jun 1;35(7):1152-1153. - PMID 33946092